Literature DB >> 19798075

NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations.

S J Chapman1, C C Khor, F O Vannberg, A Rautanen, S Segal, C E Moore, R J O Davies, N P Day, N Peshu, D W Crook, J A Berkley, T N Williams, J A Scott, A V S Hill.   

Abstract

The proinflammatory transcription factor nuclear factor-kappaB (NF-kappaB) has a central role in host defence against pneumococcal disease. Both rare mutations and common polymorphisms in the NFKBIA gene encoding the NF-kappaB inhibitor, IkappaB-alpha, associate with susceptibility to bacterial disease, but the possible role of polymorphisms within the related IkappaB-zeta gene NFKBIZ in the development of invasive pneumococcal disease (IPD) has not been reported previously. To investigate this further, we examined the frequencies of 22 single-nucleotide polymorphisms spanning NFKBIZ in two case-control studies, comprising UK Caucasian (n=1008) and Kenyan (n=723) individuals. Nine polymorphisms within a single UK linkage disequilibrium (LD) block and all four polymorphisms within the equivalent, shorter Kenyan LD block displayed either a significant association with IPD or a trend towards association. For each polymorphism, heterozygosity was associated with protection from IPD when compared with the combined homozygous states (for example, for rs600718, Mantel-Haenszel 2 x 2 chi(2)=7.576, P=0.006, odds ratio (OR)=0.67, 95% confidence interval (95% CI) for OR: 0.51-0.88; for rs616597, Mantel-Haenszel 2 x 2 chi(2)=8.715, P=0.003, OR=0.65, 95% CI: 0.49-0.86). We conclude that multiple NFKBIZ polymorphisms associate with susceptibility to IPD in humans. The study of multiple populations may aid in fine mapping of associations within extensive regions of strong LD ('transethnic mapping').

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798075      PMCID: PMC3051152          DOI: 10.1038/gene.2009.76

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  36 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei.

Authors:  S Yamazaki; T Muta; K Takeshige
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

Review 3.  The use of MassARRAY technology for high throughput genotyping.

Authors:  Christian Jurinke; Dirk van den Boom; Charles R Cantor; Hubert Köster
Journal:  Adv Biochem Eng Biotechnol       Date:  2002       Impact factor: 2.635

4.  Early predictors of mortality in pneumococcal bacteraemia.

Authors:  I Balakrishnan; P Crook; R Morris; S H Gillespie
Journal:  J Infect       Date:  2000-05       Impact factor: 6.072

5.  MBL genotype and risk of invasive pneumococcal disease: a case-control study.

Authors:  Suchismita Roy; Kyle Knox; Shelley Segal; David Griffiths; Catrin E Moore; Kenneth I Welsh; Alex Smarason; Nicholas P Day; William L McPheat; Derrick W Crook; Adrian V S Hill
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

Review 6.  The burden of invasive pneumococcal disease and the potential for reduction by immunisation.

Authors:  Helena K Parsons; David H Dockrell
Journal:  Int J Antimicrob Agents       Date:  2002-02       Impact factor: 5.283

Review 7.  Balanced polymorphism selected by genetic versus infectious human disease.

Authors:  Michael Dean; Mary Carrington; Stephen J O'Brien
Journal:  Annu Rev Genomics Hum Genet       Date:  2002-04-15       Impact factor: 8.929

Review 8.  Haplotype blocks and linkage disequilibrium in the human genome.

Authors:  Jeffrey D Wall; Jonathan K Pritchard
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

9.  Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics.

Authors:  Simon Mead; Michael P H Stumpf; Jerome Whitfield; Jonathan A Beck; Mark Poulter; Tracy Campbell; James B Uphill; David Goldstein; Michael Alpers; Elizabeth M C Fisher; John Collinge
Journal:  Science       Date:  2003-04-10       Impact factor: 47.728

10.  Interleukin-17A mediates acquired immunity to pneumococcal colonization.

Authors:  Ying-Jie Lu; Jane Gross; Debby Bogaert; Adam Finn; Linda Bagrade; Qibo Zhang; Jay K Kolls; Amit Srivastava; Anna Lundgren; Sophie Forte; Claudette M Thompson; Kathleen F Harney; Porter W Anderson; Marc Lipsitch; Richard Malley
Journal:  PLoS Pathog       Date:  2008-09-19       Impact factor: 6.823

View more
  19 in total

1.  Natural selection in a bangladeshi population from the cholera-endemic ganges river delta.

Authors:  Elinor K Karlsson; Jason B Harris; Shervin Tabrizi; Atiqur Rahman; Ilya Shlyakhter; Nick Patterson; Colm O'Dushlaine; Stephen F Schaffner; Sameer Gupta; Fahima Chowdhury; Alaullah Sheikh; Ok Sarah Shin; Crystal Ellis; Christine E Becker; Lynda M Stuart; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri; Pardis C Sabeti; Regina C Larocque
Journal:  Sci Transl Med       Date:  2013-07-03       Impact factor: 17.956

2.  IκBζ controls IL-17-triggered gene expression program in intestinal epithelial cells that restricts colonization of SFB and prevents Th17-associated pathologies.

Authors:  Soh Yamazaki; Naohiro Inohara; Masaki Ohmuraya; Yousuke Tsuneoka; Hideo Yagita; Takaharu Katagiri; Takashi Nishina; Tetuo Mikami; Hiromasa Funato; Kimi Araki; Hiroyasu Nakano
Journal:  Mucosal Immunol       Date:  2022-08-24       Impact factor: 8.701

3.  Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.

Authors:  Daniel G Camblor; Daniel Miranda; Guillermo M Albaiceta; Laura Amado-Rodríguez; Elías Cuesta-Llavona; Daniel Vázquez-Coto; Julia Gómez de Oña; Claudia García-Lago; Juan Gómez; Eliecer Coto
Journal:  Hum Immunol       Date:  2022-06-21       Impact factor: 2.211

Review 4.  Human genetic susceptibility to infectious disease.

Authors:  Stephen J Chapman; Adrian V S Hill
Journal:  Nat Rev Genet       Date:  2012-02-07       Impact factor: 53.242

5.  Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.

Authors:  Jairam R Lingappa; Logan Dumitrescu; Shanta M Zimmer; Ruth Lynfield; Janet M McNicholl; Nancy E Messonnier; Cynthia G Whitney; Dana C Crawford
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

Review 6.  Evolution, revolution and heresy in the genetics of infectious disease susceptibility.

Authors:  Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

7.  Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study.

Authors:  Stephen J Chapman; Chiea C Khor; Fredrik O Vannberg; Anna Rautanen; Andrew Walley; Shelley Segal; Catrin E Moore; Robert J O Davies; Nicholas P Day; Norbert Peshu; Derrick W Crook; James A Berkley; Thomas N Williams; J Anthony Scott; Adrian V S Hill
Journal:  Crit Care       Date:  2010-12-20       Impact factor: 9.097

8.  FGF10 Triggers De Novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells.

Authors:  Sara Taghizadeh; Cho-Ming Chao; Stefan Guenther; Lea Glaser; Luisa Gersmann; Gabriela Michel; Simone Kraut; Kerstin Goth; Janine Koepke; Monika Heiner; Ana Ivonne Vazquez-Armendariz; Susanne Herold; Christos Samakovlis; Norbert Weissmann; Francesca Ricci; Giorgio Aquila; Laurent Boyer; Harald Ehrhardt; Parviz Minoo; Saverio Bellusci; Stefano Rivetti
Journal:  Stem Cells       Date:  2022-06-22       Impact factor: 5.845

9.  Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.

Authors:  Magda K Ellis; Katherine S Elliott; Anna Rautanen; Derrick W Crook; Adrian V S Hill; Stephen J Chapman
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

10.  Genetic factors regulating lung vasculature and immune cell functions associate with resistance to pneumococcal infection.

Authors:  Magda S Jonczyk; Michelle Simon; Saumya Kumar; Vitor E Fernandes; Nicolas Sylvius; Ann-Marie Mallon; Paul Denny; Peter W Andrew
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.